At the news
? NEUTRALIMPACT 5/10 425 filed Oct 21, 2026 at 15:05 ET
AkzoNobel provided an investor presentation confirming the Axalta merger remains on track to close in early 2027, with two-thirds of regulatory approvals secured and only two small divestitures required (AkzoNobel's European VR business and Axalta's North American Wood business, combined <€500M revenue). The $600M cost synergy target is reaffirmed as independent of remedies, and an EGM to appoint three Axanzo directors is set for November 30, 2026.
- Merger on track to close in early 2027, with two-thirds of regulatory approvals secured
- Remedies: divestiture of AkzoNobel's European VR business and Axalta's North American Wood business (<€500M combined revenue)
- $600M cost synergies reaffirmed, ~90% within 3 years of closing, plus 100-200bps revenue synergy uplift
- EGM to appoint three Axanzo directors scheduled for November 30, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access